The Dialysis Market was valued at USD 96.75 Bn in 2022 and is expected to reach USD 151.89 Bn by 2030 and grow at a CAGR of 5.8% over the forecast period of 2023-2030.
Dialysis is a medical therapy that assists the kidneys in performing their tasks when they are no longer able to do so properly. The kidneys' major role is to filter waste materials, excess fluids, and electrolytes from the blood while also maintaining a good chemical balance in the body. Dialysis is used to accomplish these critical processes artificially when the kidneys are damaged or not functioning adequately owing to illnesses such as kidney failure or end-stage renal disease (ESRD).
To get more information on Dialysis Market - Request Free Sample Report
There are two types of dialysis, Hemodialysis: The patient's blood is pumped out of their body and through a machine called a dialyzer or hemodialyzer during hemodialysis. This equipment filters the blood to eliminate waste products and excess fluids, acting as an artificial kidney. After cleaning, the blood is returned to the patient's body. Hemodialysis is typically done in a dialysis center, and each session can last several hours. It is usually done three times per week.
Peritoneal Dialysis: This type of dialysis is done inside the body. A catheter is inserted into the patient's abdominal cavity, and dialysate, a specific fluid, is delivered into the peritoneal cavity. This fluid aids in the removal of waste materials and excess fluids from the peritoneum (the lining of the abdominal cavity).
The rise in the need of the dialysis treatment.
Over time, there is a gradual and cumulative decline of kidney function. Diabetes, high blood pressure (hypertension), autoimmune diseases, and some genetic disorders can also cause it. Diabetes is one of the most common causes of renal failure. High blood sugar levels can damage the blood vessels in the kidneys over time, limiting their ability to function correctly.
The adverse health status of the patient which disqualifies them for dialysis.
Rise in the research and funding from the government.
Governments frequently control and supervise the quality of dialysis services supplied, ensuring that standards of care are met and patients receive safe and effective therapy. Some governments may grant funds for research and innovation in the field of renal care, which can lead to breakthroughs in dialysis technology and treatment approaches.
The limited resources which include economic factors, lack of infrastructure.
Impact of Recession
Recessions can have a variety of effects on dialysis and the healthcare system as a whole. The intensity and duration of the recession, as well as the healthcare policies and infrastructure in place, can all have an impact on the magnitude of these consequences. Here are some of the ways a recession could influence dialysis.
Recessions frequently result in job losses, lower income, and financial troubles for individuals and families. For dialysis patients, the costs of treatment, including sessions, drugs, and related medical bills, may become even more expensive. During a recession, people may have difficulty accessing healthcare services due to factors such as reduced insurance coverage, fewer available medical facilities, and lengthier treatment wait lists.
Impact of Russia Ukraine War
Inflict can cause harm or ruin to healthcare facilities such as dialysis centers and hospitals. As a result, the capacity to deliver dialysis therapy to patients in affected locations may be diminished. The violence may interrupt international supply chains for medical equipment like as dialysis machines, pharmaceuticals, and other supplies. This could result in shortages or delays in getting necessary materials for dialysis treatment.
Conflict-related population displacement might result in the migration of patients who require regular dialysis treatment. This can make it difficult for them to receive consistent and timely care.
Drugs and Services
By End User
Need any customization research on Dialysis Market - Enquiry Now
Rest of Eastern Europe
Rest of Western Europe
Rest of Asia Pacific
Middle East & Africa
Rest of Middle East
Rest of Africa
Rest of Latin America
The major key players are Asahi Kasei, Nikkiso, Fresenius Se and CO, KGAA, Nipro Corporation, Becton, Dickinson and Company, Diaverum, Deutschland, Baxter International, B Braun Melesungen.
Nikkiso-Company Financial Analysis
North America is one of the world's largest dialysis markets. Examine the market size and historical growth rates, taking into account factors such as the aging population, the increased frequency of chronic kidney disease (CKD), and advances in dialysis technology. The access of the healthcare for the patients suffering from kidney is easier compared to other regions. Also, the infrastructure and the facilities contribute to the growth of the dialysis market in this region.
APAC will be the region with the highest CAGR growth rate, due to reasons such as the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), as well as developments in healthcare infrastructure, APAC is a rapidly growing market for dialysis.
Asahi Kasei – The acquisition of Bionova Scientifics by the company I order to improve its current offerings.
Baxter International- The company has officially announced strategic actions in order to improve the operations effectiveness, and accelerate innovation.
|Market Size in 2022
|US$ 96.75 Bn
|Market Size by 2030
|US$ 151.89 Bn
|CAGR of 5.8% From 2023 to 2030
|Report Scope & Coverage
|Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
|• By Type (Hemodialysis, Peritoneal Dialysis)
• By Product (Equipment, Consumables, Drugs and Services)
• By End User (Incenter Dialysis, Home Dialysis)
|North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)
|Asahi Kasei, Nikkiso, Fresenius Se and CO, KGAA, Nipro Corporation, Becton, Dickinson and Company, Diaverum, Deutschland, Baxter International, B Braun Melesungen.
|• The rise in the need of the dialysis treatment.
|• The adverse health status of the patient which disqualifies them for dialysis.
Ans: The Dialysis Market is expected to grow at a CAGR of 4.8 %.
Ans: The Dialysis Market was valued at USD 93 Bn in 2022 and is expected to reach USD 135 Bn by 2030 and grow at a CAGR of 4.8% over the forecast period of 2023-2030.
Ans: The rise in the need of the dialysis treatment.
Ans: The adverse health status of the patient which disqualifies them for dialysis.
Ans: North America overtook other regional markets as the largest market for Dialysis, with the highest revenue share.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 Impact of Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.2 Impact on major economies
126.96.36.199 United Kingdom
188.8.131.52 South Korea
184.108.40.206 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Dialysis Market, By Type
8.2 Peritoneal Dialysis
9. Dialysis Market, By Product
9.3 Drugs and Services
10. Dialysis Market, By End User
10.1 Incenter Dialysis
10.2 Home Dialysis
11. Regional Analysis
11.2 North America
11.2.1 North America Dialysis Market by Country
11.2.2North America Dialysis Market by Type
11.2.3 North America Dialysis Market by Product
11.2.4 North America Dialysis Market by End User
220.127.116.11 USA Dialysis Market by Type
18.104.22.168 USA Dialysis Market by Product
22.214.171.124 USA Dialysis Market by End User
126.96.36.199 Canada Dialysis Market by Type
188.8.131.52 Canada Dialysis Market by Product
184.108.40.206 Canada Dialysis Market by End User
220.127.116.11 Mexico Dialysis Market by Type
18.104.22.168 Mexico Dialysis Market by Product
22.214.171.124 Mexico Dialysis Market by End User
11.3.1 Eastern Europe
126.96.36.199 Eastern Europe Dialysis Market by country
188.8.131.52 Eastern Europe Dialysis Market by Type
184.108.40.206 Eastern Europe Dialysis Market by Product
220.127.116.11 Eastern Europe Dialysis Market by End User
18.104.22.168.1 Poland Dialysis Market by Type
22.214.171.124.2 Poland Dialysis Market by Product
126.96.36.199.3 Poland Dialysis Market by End User
188.8.131.52.1 Romania Dialysis Market by Type
184.108.40.206.2 Romania Dialysis Market by Product
220.127.116.11.4 Romania Dialysis Market by End User
18.104.22.168.1 Turkey Dialysis Market by Type
22.214.171.124.2 Turkey Dialysis Market by Product
126.96.36.199.3 Turkey Dialysis Market by End User
188.8.131.52 Rest of Eastern Europe
184.108.40.206.1 Rest of Eastern Europe Dialysis Market by Type
220.127.116.11.2 Rest of Eastern Europe Dialysis Market by Product
18.104.22.168.3 Rest of Eastern Europe Dialysis Market by End User
11.3.2 Western Europe
22.214.171.124 Western Europe Dialysis Market by Country
126.96.36.199 Western Europe Dialysis Market by Type
188.8.131.52 Western Europe Dialysis Market by Product
184.108.40.206 Western Europe Dialysis Market by End User
220.127.116.11.1 Germany Dialysis Market by Type
18.104.22.168.2 Germany Dialysis Market by Product
22.214.171.124.3 Germany Dialysis Market by End User
126.96.36.199.1 France Dialysis Market by Type
188.8.131.52.2 France Dialysis Market by Product
184.108.40.206.3 France Dialysis Market by End User
220.127.116.11.1 UK Dialysis Market by Type
18.104.22.168.2 UK Dialysis Market by Product
22.214.171.124.3 UK Dialysis Market by End User
126.96.36.199.1 Italy Dialysis Market by Type
188.8.131.52.2 Italy Dialysis Market by Product
184.108.40.206.3 Italy Dialysis Market by End User
220.127.116.11.1 Spain Dialysis Market by Type
18.104.22.168.2 Spain Dialysis Market by Product
22.214.171.124.3 Spain Dialysis Market by End User
126.96.36.199.1 Netherlands Dialysis Market by Type
188.8.131.52.2 Netherlands Dialysis Market by Product
184.108.40.206.3 Netherlands Dialysis Market by Test Type
220.127.116.11.1 Switzerland Dialysis Market by Type
18.104.22.168.2 Switzerland Dialysis Market by Product
22.214.171.124.3 Switzerland Dialysis Market by End User
126.96.36.199.1 Austria Dialysis Market by Type
188.8.131.52.2 Austria Dialysis Market by Product
184.108.40.206.3 Austria Dialysis Market by End User
220.127.116.11 Rest of Western Europe
18.104.22.168.1 Rest of Western Europe Dialysis Market by Type
22.214.171.124.2 Rest of Western Europe Dialysis Market by Product
126.96.36.199.3 Rest of Western Europe Dialysis Market by End User
11.4.1 Asia-Pacific Dialysis Market by country
11.4.2 Asia-Pacific Dialysis Market by Type
11.4.3 Asia-Pacific Dialysis Market by Product
11.4.4 Asia-Pacific Dialysis Market by End User
188.8.131.52 China Dialysis Market by Type
184.108.40.206 China Dialysis Market by End User
220.127.116.11 China Dialysis Market by Product
18.104.22.168 India Dialysis Market by Type
22.214.171.124 India Dialysis Market by Product
126.96.36.199 India Dialysis Market by End User
188.8.131.52 Japan Dialysis Market by Type
184.108.40.206 Japan Dialysis Market by Product
220.127.116.11 Japan Dialysis Market by End User
11.4.8 South Korea
18.104.22.168 South Korea Dialysis Market by Type
22.214.171.124 South Korea Dialysis Market by Product
126.96.36.199 South Korea Dialysis Market by End User
188.8.131.52 Vietnam Dialysis Market by Type
184.108.40.206 Vietnam Dialysis Market by Product
220.127.116.11 Vietnam Dialysis Market by End User
18.104.22.168 Singapore Dialysis Market by Type
22.214.171.124 Singapore Dialysis Market by Product
126.96.36.199 Singapore Dialysis Market by End User
188.8.131.52 Australia Dialysis Market by Type
184.108.40.206 Australia Dialysis Market by Product
220.127.116.11 Australia Dialysis Market by End User
11.4.12 Rest of Asia-Pacific
18.104.22.168 Rest of Asia-Pacific Dialysis Market by Type
22.214.171.124 Rest of Asia-Pacific Dialysis Market by Product
126.96.36.199 Rest of Asia-Pacific Dialysis Market by Test Type
11.5 Middle East & Africa
11.5.1 Middle East
188.8.131.52 Middle East Dialysis Market by country
184.108.40.206 Middle East Dialysis Market by Type
220.127.116.11 Middle East Dialysis Market by Product
18.104.22.168 Middle East Dialysis Market by End User
22.214.171.124.1 UAE Dialysis Market by Type
126.96.36.199.2 UAE Dialysis Market by Product
188.8.131.52.3 UAE Dialysis Market by End User
184.108.40.206.1 Egypt Dialysis Market by Type
220.127.116.11.2 Egypt Dialysis Market by Product
18.104.22.168.3 Egypt Dialysis Market by End User
22.214.171.124 Saudi Arabia
126.96.36.199.1 Saudi Arabia Dialysis Market by Type
188.8.131.52.2 Saudi Arabia Dialysis Market by Product
184.108.40.206.3 Saudi Arabia Dialysis Market by End User
220.127.116.11.1 Qatar Dialysis Market by Type
18.104.22.168.2 Qatar Dialysis Market by Product
22.214.171.124.3 Qatar Dialysis Market by End User
126.96.36.199 Rest of Middle East
188.8.131.52.1 Rest of Middle East Dialysis Market by Type
184.108.40.206.2 Rest of Middle East Dialysis Market by Product
220.127.116.11.3 Rest of Middle East Dialysis Market by End User
18.104.22.168 Africa Transfusion Diagnostics Market by country
22.214.171.124 Africa Dialysis Market by Type
126.96.36.199 Africa Dialysis Market by Product
188.8.131.52 Africa Dialysis Market by End User
184.108.40.206.1 Nigeria Dialysis Market by Type
220.127.116.11.2 Nigeria Dialysis Market by Product
18.104.22.168.3 Nigeria Dialysis Market by End User
22.214.171.124 South Africa
126.96.36.199.1 South Africa Dialysis Market by Type
188.8.131.52.2 South Africa Dialysis Market by Product
184.108.40.206.3 South Africa Dialysis Market by End User
220.127.116.11 Rest of Africa
18.104.22.168.1 Rest of Africa Dialysis Market by Type
22.214.171.124.2 Rest of Africa Dialysis Market by Product
126.96.36.199.3 Rest of Africa Dialysis Market by Test type
11.6 Latin America
11.6.1 Latin America Dialysis Market by country
11.6.2 Latin America Dialysis Market by Type
11.6.3 Latin America Dialysis Market by Technique
11.6.4 Latin America Dialysis Market by End User
188.8.131.52 Brazil America Dialysis by Type
184.108.40.206 Brazil America Dialysis by Technique
220.127.116.11 Brazil America Dialysis by End User
18.104.22.168 Argentina America Dialysis by Type
22.214.171.124 Argentina America Dialysis by Technique
126.96.36.199 Argentina America Dialysis by End User
188.8.131.52 Colombia America Dialysis by Type
184.108.40.206 Colombia America Dialysis by Technique
220.127.116.11 Colombia America Dialysis by End User
11.6.8 Rest of Latin America
18.104.22.168 Rest of Latin America Dialysis by Type
22.214.171.124 Rest of Latin America Dialysis by Technique
126.96.36.199 Rest of Latin America Dialysis by End User
12. Company profile
12.1 Asahi Kasei
12.1.1 Company Overview
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2.1 Company Overview
12.2.3 Product/Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Fresenius Se and CO
12.3.1 Company Overview
12.3.3 Product/Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4.1 Company Overview
12.4.3 Product/Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Nipro Corporation
12.5.1 Company Overview
12.5.3 Product/Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Becton, Dickinson and Company
12.6.1 Company Overview
12.6.3 Product/Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7.1 Company Overview
12.7.3 Product/Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8.1 Company Overview
12.8.3 Product/Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Baxter International
12.9.1 Company Overview
12.9.3 Product/Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 B Braun Melesungen
12.10.1 Company Overview
12.10.3 Product/Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Bench marking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Ultrasound gels market size is projected to grow from $95.85 million in 2022 to $124.2 million by 2030, at a CAGR of 3.3% during the forecast period.
The Life Science Tools Market size was estimated USD 145.01 billion in 2022 and is expected to reach USD 331.7 billion by 2030 at a CAGR of 10.9% during the forecast period of 2023-2030.
Pancreatic Cancer Treatment Market size was valued at USD 2.8 billion in 2022 and is estimated to reach at USD 9.05 billion in 2030 and grow at a compound annual growth rate approx. CAGR of 15.8% predicted for the forecast period of 2023-2030.
The Conjunctivitis Treatment Market size was USD 4.18 Billion in 2022 and is expected to Reach USD 5.72 Billion by 2030 and grow at a CAGR of 4% over the forecast period of 2023-2030.
The Epilepsy Surgery Market Size was valued at USD 980 million in 2022 and is expected to reach USD 1483.5 million by 2030 and grow at a CAGR of 5.32% over the forecast period 2023-2030.
The Clinical Trial Imaging Market Size was valued at USD 925.01 million in 2022, and is expected to reach USD 1818 million by 2030 and grow at a CAGR of 8.8% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone